pαH-S-GSAS-2P-Omicron-BA.5
(Plasmid
#213828)
-
PurposeMammalian cell expression of SARS-CoV-2 Spike protein of OMICRON.2P.BA5 variant
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 213828 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepαH
- Backbone size w/o insert (bp) 4746
- Total vector size (bp) 8355
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namepαH-S-GSAS/Omicron-2P-BA5
-
Insert Size (bp)3609
-
MutationG339D,R346T,S371F,S373P,S375F,T376A,D405N,R408S,K417N,N440K,L452R, S477N,T478K,E484A,F486V,Q498R,N501Y,Y505H,H655Y,N679K,P681H,N764K,D796Y,Q954H,N969K, K986P, V987P
-
Entrez GeneS (a.k.a. GU280_gp02, spike glycoprotein)
-
Tag
/ Fusion Protein
- HRV 3C cleavage site (before tags) 8X His tag 2X Strep-Tag II (C terminal on backbone)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer cctctgctaaccatgttcatgc (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
A portion of this plasmid was derived from a plasmid made by Jason McLellan; Terms and Licences: UBMTA, Not available to Industry; see this as a reference: https://www.addgene.org/164566/
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pαH-S-GSAS-2P-Omicron-BA.5 was a gift from Priyamvada Acharya (Addgene plasmid # 213828 ; http://n2t.net/addgene:213828 ; RRID:Addgene_213828) -
For your References section:
SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition. Zhang QE, Lindenberger J, Parsons R, Thakur B, Parks R, Park CS, Huang X, Sammour S, Janowska K, Spence TN, Edwards RJ, Martin M, Williams WB, Gobeil S, Montefiori DC, Korber B, Saunders KO, Haynes BF, Haynes BF, Henderson R, Acharya P. bioRxiv [Preprint]. 2024 Mar 12:2024.02.12.580004. doi: 10.1101/2024.02.12.580004. 10.1101/2024.02.12.580004 PubMed 38405707